Shares in Applied Nutrition surged by approximately 8% on Tuesday after the company upgraded its earnings outlook for the year, capitalising on the booming health and nutrition market. The London-listed sports health business, which is backed by television personality Coleen Rooney, has seen a robust start to its stock market debut with a valuation hovering around £350 million.
Strong Sales Performance Exceeds Expectations
The company reported that sales for the first half of its financial year have surpassed initial group expectations. This positive performance is largely attributed to the "peak" January period, when demand for health and fitness products traditionally rebounds after the Christmas holidays and New Year's resolutions kick in.
Retail Partnerships Drive Growth
Applied Nutrition informed investors that orders from its retail partners, along with resulting stock levels in stores, were significantly higher than forecasted for the period. The firm has successfully targeted a diverse range of UK retailers, including high street chains, major grocers, and discount stores, which has been a key driver of this growth.
Coupled with increased demand for several recent product launches, the company now anticipates a stronger revenue performance over the six months ending in January. As a result, Applied Nutrition is forecasting full-year revenues of around £140 million, up from the previous analyst expectation of £133.5 million.
Business Model and Global Reach
Applied Nutrition primarily operates by selling its products to other businesses, including retailers, grocers, gyms, and sports clubs. The company targets a wide consumer base, from professional athletes to individuals seeking weight loss or muscle-building solutions. Its products are available in more than 80 countries worldwide, and it also maintains an e-commerce website for direct online shopping.
Coleen Rooney's Expanding Role
Last week, the company revealed that Coleen Rooney has significantly increased her stake in the business. Rooney, who was one of the initial investors during the firm's flotation in 2024, has recently co-launched her own line of products for the brand. This new range includes collagen supplements and powders designed to target sleep, immunity, hydration, and debloating.
Applied Nutrition's chief executive, Thomas Ryder, emphasised that Rooney's involvement has been instrumental in broadening the brand's customer base and raising awareness among health-conscious consumers. Her endorsement and product line have contributed to the company's enhanced market presence and sales momentum.
The upgraded earnings outlook reflects Applied Nutrition's strategic positioning in the competitive health sector, leveraging both retail partnerships and celebrity backing to drive growth. As the health and wellness trend continues to gain traction, the company is well-placed to maintain its upward trajectory in the coming months.
